Analytical Data
-
Gene name
CYTSB
- Application
-
Alternative Names
SPECC1; NSP5; HCMOGT-1; Nuclear structure protein 5; Sperm Antigen With Calponin Homology And Coiled-Coil Domains 1; Cytokinesis And Spindle Organization B
-
Species
Mouse
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q5SXY1
-
Expression Region
Gly961~Lys1063
-
Molecular Weight
16kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CYTSB, or cytochrome b, is an integral membrane protein that plays a critical role in electron transport and cellular respiration in various organisms, including bacteria and eukaryotes. The study of CYTSB is particularly significant due to its involvement in energy metabolism and its potential applications in biotechnology and medicine. In recent years, researchers have focused on the recombinant expression and characterization of CYTSB to better understand its structure-function relationship and mechanisms of action. This has been driven by the need for efficient bioenergetic systems and the exploration of CYTSB as a target for drug development, particularly in combating diseases linked to mitochondrial dysfunction. The advances in recombinant DNA technology have enabled the production of CYTSB in heterologous systems, allowing for detailed biochemical analysis and functional studies. Understanding the properties of CYTSB at a molecular level can provide insights into cellular processes and pave the way for the engineering of novel bioenergetic pathways, which could have profound implications for energy sustainability and therapeutic applications. As such, the research surrounding CYTSB continues to be of paramount importance in both fundamental and applied sciences.
